How should HIT be treated and thrombotic complications reduced?
Completely discontinuing all use of heparin is mandatory.[7,25,28,30] An optimal agent to treat HIT would not cross-react with heparin/PF4 antibodies and would be a potent antithrombotic. In addition, it should be fast-acting, reasonably well tolerated, easy to monitor, and have a short half-life.